Reduction of skin sensitization in electrotransport drug delivery
US5995869A · kind A · utility
112Cited by
14References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 11, 1997 |
| Grant date | Nov 30, 1999 |
| Priority date | — |
| Expiry date | Jun 11, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N1/30
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
A device and method are provided for reducing or preventing skin sensitization in electrotransport drug delivery. The method involves co-administration of a countersensitizing agent, comprising cis-urocanic acid or an analog thereof, with the drug delivered via electrotransport. Novel drug reservoirs and electrotransport drug delivery systems, formulated with a countersensitizing agent as described herein, are provided as well.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.